Picture of Steris logo

STE — Steris News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Steris Plc Expected To Post Earnings Of $2.35 A Share: Earnings Preview

* STERIS plc  STE.N   STE  is expected to show a rise in
quarterly
revenue when it reports  results on May 8 for the period ending
March 31 2024
    * The Dublin Ireland; Republic of-based   company is
expected to
report a 1.9% increase in revenue to $1.411 billion from $1.38
billion a year ago, according to the mean estimate from 6
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for STERIS plc is for
earnings of
$2.35 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for STERIS plc
is
$241.01​, above​ its last closing price of $209.52. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  2.17        2.17       2.22      Beat    2.3
 Sep. 30 2023  2.00        2.00       2.03      Beat    1.3
 Jun. 30 2023  1.86        1.87       2.00      Beat    7.1​
 Mar. 31 2023  2.15        2.15       2.30      Beat    7.1
 ​​Dec.        2.20        2.19       2.02      Missed  -7.9
 31 2022                                                
 Sep. 30 2022  1.99                   1.99              0.3​
 Jun. 30 2022  1.92        1.92       1.90      Missed  -0.8
 Mar. 31 2022  2.02        2.02       2.04      Beat    0.9
 This summary was machine generated May 7 at 00:11 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Steris

See all news